On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Molecure Spolka Akcyjna's own share of each project, not the project's full budget.
- Horizon 2020€616k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- PRECIOUSPartner
Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy
Horizon 2020 · 2016–2022 · Project on CORDIS ↗
€616ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Stichting Radboud UniversiteitNetherlands · 1 shared project
- Stichting Radboud Universitair Medisch CentrumNetherlands · 1 shared project
- Universitat KonstanzGermany · 1 shared project
- Fondazione Irccs Istituto Nazionale Dei TumoriItaly · 1 shared project
- Evonik Operations GmbHGermany · 1 shared project
- Ustav Makromolekularni Chemie Av CrvviCzech Republic · 1 shared project
- PNO Life Sciences & Health B.V.Netherlands · 1 shared project
- Specialized Medical Services-Oncology BVNetherlands · 1 shared project
- Iteos TherapeuticsBelgium · 1 shared project
- Iox Therapeutics LimitedUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- immunotherapy
- nanomedicine
- oncology
- surgery
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.